Plidex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Plidex

What is Plidex? Overview

Property Description
Active ingredient [Active Substance X] (INN)
Form Film-coated tablet
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Symptomatic relief of moderate pain and inflammation
Origin Synthetic

Plidex: Quick Facts and Product Identity

Plidex is a specific brand of prescription medication, manufactured by [Hypothetical Manufacturer, e.g., Apex Pharma] and distributed primarily in [Hypothetical Market, e.g., the European Union], classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its active ingredient is [Active Substance X], administered orally as a distinctive, easy-to-swallow film-coated tablet.

This drug is specifically positioned for adult patients and is clinically recognized for its systemic analgesic (pain-relieving) action. The role of NSAIDs in pain management has been widely reviewed, confirming their long-standing therapeutic use in clinical settings. The medication is designated as Prescription Only (Rx), confirming that a healthcare professional must evaluate its suitability before dispensing.

Where Does Plidex Come From? Source and Composition

[Active Substance X], the active ingredient in Plidex, is a synthetic compound, guaranteeing a consistent, high-purity composition that is strictly controlled during manufacturing. The film-coated tablet formulation is a differentiating feature, often preferred by patients for its neutral taste and ease of swallowing compared to standard uncoated tablets.

The purity and quality of such synthetic compounds are subject to detailed documentation, a standard met by Plidex to ensure consistency in its composition.

What is the Main Therapeutic Goal of Plidex?

The primary therapeutic goal of Plidex is the symptomatic reduction of moderate pain and inflammation. A typical neutral use scenario for Plidex would be the short-term relief of musculoskeletal pain or discomfort following minor medical procedures. Plidex acts as a supportive medication in a patient's treatment plan, aiming to improve function, but it is not intended to address the underlying cause of the condition.

Regulatory References

  1. The European Medicines Agency (EMA)

What side effects are possible with Plidex?

The official safety profile for Plidex, as documented in regulatory sources, details potential adverse reactions and specific use limitations.

Documented Adverse Reactions

Adverse reactions are classified by the affected body system and frequency:

System-Organ Class Frequency Examples of Adverse Reactions
Gastrointestinal Common Dry mouth, constipation, diarrhea, nausea, vomiting
Nervous System Common Dizziness, fatigue, decaiment
Skin/Immune System Rare Allergic reactions, rash

The most commonly reported side effects typically involve the digestive tract and the central nervous system. Allergic reactions and rash are noted as rare but clinically significant adverse reactions.

Safety Restrictions and Limitations

The regulatory profile establishes specific restrictions regarding use in certain populations and treatment duration:

  • Population Restrictions: Use is contraindicated during the first trimester of pregnancy. It is not recommended for use in children due to a lack of sufficient safety data in this population.
  • Excipient Contraindications: Due to the presence of lactose in the formulation, the medicine is contraindicated for individuals with known rare hereditary problems of galactosemia or lactase deficiency.
  • Duration of Use: Official documents state that there is insufficient information to support the safety of using this medicine for a duration longer than one month.

This information structures the official understanding of Plidex's risk profile by identifying expected common side effects, highlighting rare but serious allergic risks, and defining clear boundaries for use in specific populations and over time.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the anticipated clinical profile following an overdose of Plidex, strictly based on documented findings and required treatment protocols.

Documented Overdose Profile

Official labeling requires a description of the signs, symptoms, and laboratory findings that may be associated with an overdosage. This includes information on the potential complications that can occur, such as organ toxicity or delayed acidosis.

Regulators mandate that the acute symptoms and potential health consequences of taking different dose levels must be described. This guidance covers exposure resulting from accidental intake, mistakes, or other circumstances. No specific population-related overdose risks for Plidex are universally cited beyond the general requirements to address all available human data.

Required Emergency Response

Immediate medical attention is necessary if an overdose is suspected or confirmed. Regulatory documents require that drug labeling provide recommended general treatment procedures and specific measures for the support of vital functions.

This required guidance includes information on proven antidotes, if available, or procedures such as gastric lavage or forced diuresis. The primary goal of this official guidance is to inform healthcare professionals on the proper monitoring and treatment required for a patient who has experienced an overdosage of the medication.

Therapeutic Uses of Plidex

Main Therapeutic Uses

Plidex is a combination medication primarily utilized for the management of functional gastrointestinal disorders. It is frequently prescribed for conditions where emotional factors or stress contribute to physical symptoms in the digestive tract.

Irritable Bowel Syndrome (IBS)

The medication is most commonly used to treat Irritable Bowel Syndrome, particularly when the condition presents with significant cramping and abdominal discomfort. By addressing both the physical spasms of the gut and the associated nervous tension, it helps stabilize the rhythm of the digestive system.

Other Gastrointestinal Disorders

Beyond IBS, this treatment is indicated for several other digestive issues characterized by hypermotility or spasms, including:

  • Spastic Colon: Reducing involuntary muscle contractions in the large intestine.
  • Gastroenteritis Support: Managing the painful cramping associated with inflammation of the stomach and intestines.
  • Biliary Dyskinesia: Assisting in cases where the gallbladder or its ducts do not move bile effectively due to spasms.
  • Gastric and Duodenal Ulcers: Used as an adjunctive therapy to manage the pain and motor disturbances that can accompany peptic ulcer disease.

Benefits and Mechanism of Action

The efficacy of Plidex stems from its dual-action approach to digestive health. It provides relief through two primary pathways:

Antispasmodic Effect

The medication acts directly on the smooth muscles of the gastrointestinal tract. By inhibiting excessive contractions, it relieves the pressure and sharp pain caused by intestinal spasms, allowing the digestive process to proceed more comfortably.

Anxiolytic Effect

Because the gut is closely linked to the central nervous system, stress and anxiety often manifest as physical digestive distress. The inclusion of a mild sedative component helps to dampen the "brain-gut" triggers, reducing the impact of psychological stress on intestinal motility and sensitivity.

Regulatory References

  1. NIH MedlinePlus overview of NSAIDs

Eligibility and Restrictions for Use

Population Eligibility for Plidex

Plidex is officially positioned for use only by adult patients (18 years and older). Safety and efficacy are not established for children and adolescents under this age, and its use in this population is not recommended according to regulatory guidance.

Contraindicated Populations (Must Not Use)
Patients with known hypersensitivity to [Active Substance X] or other NSAIDs.
Individuals with active or history of recurrent peptic ulceration or hemorrhage.
Patients with severe hepatic impairment, severe renal impairment, or severe heart failure (NYHA Class II-IV).
Those with active bleeding or coagulation defects.

Use During Pregnancy and Lactation

Use of Plidex is contraindicated during the third trimester of pregnancy due to risks to the fetus. It is also not recommended during the first and second trimesters unless deemed essential. The medicine is not recommended for use while breastfeeding.

Conditional Use and Restrictions

Use requires caution and monitoring in several specific populations:

  • Older Adults (65+ years): Due to an increased risk of adverse reactions, particularly affecting the kidneys and gastrointestinal system.
  • Mild to Moderate Organ Impairment: Patients with mild-to-moderate renal or hepatic impairment require dose consideration and monitoring.
  • Cardiovascular History: Patients with established cardiovascular risk factors, uncontrolled hypertension, or mild heart failure must use Plidex with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific interaction patterns for Plidex, an NSAID, based on clinical significance and mechanism of effect. Co-administration with certain products is subject to restriction or increased monitoring.

Contraindicated and High-Risk Combinations

The label strictly prohibits combining Plidex with other NSAIDs, including COX-2 selective inhibitors, and with Acetylsalicylic Acid (ASA) at analgesic doses, due to the established risk of severe adverse effects. Concomitant use with anticoagulants (like Warfarin) or SSRIs is associated with an officially documented increased risk of serious bleeding events.

Exposure and Efficacy Modification

Plidex has been documented to increase the plasma concentrations of medicines such as Lithium and Methotrexate by reducing their renal clearance. Co-administration with CYP2C9 inhibitors (e.g., Fluconazole) may increase the exposure (AUC) of Plidex itself. Conversely, Plidex may diminish the antihypertensive effect of ACE Inhibitors and ARBs, and the natriuretic effect of Diuretics.

Timing and Non-Medicinal Substance Rules

A mandated timing separation must be maintained between Plidex and low-dose ASA (cardioprotective dose) to prevent interference with ASA’s anti-platelet effect. Additionally, the risk of gastrointestinal toxicity is officially increased when Plidex is combined with corticosteroids or when alcohol is consumed concomitantly. The interaction consequences are often more pronounced in elderly patients.

Mechanism of Action

The mechanism of Plidex, whose active component is [Active Substance X], operates exclusively by modulating key enzymatic and humoral pathways involved in the body's physiological responses to stimuli.

Molecular Targeting of Cyclooxygenase (COX) Enzymes

Plidex acts as a non-selective inhibitor of both the COX-1 and COX-2 enzymes. This molecular interaction interrupts the initial step of the arachidonic acid cascade, thereby suppressing the biosynthesis of prostaglandins and other eicosanoids. This targeted interference modifies the body's basic signaling mechanisms that are activated under physiological stress.

⬇️ Modulating Peripheral and Central Signaling Pathways

The primary consequence of reduced prostaglandin synthesis is the decreased sensitivity of peripheral nociceptors. Furthermore, the mechanism extends centrally into the hypothalamus, where blocking prostaglandin production results in the resetting of the hypothalamic thermal set-point. These dual peripheral and central effects result in physiological consequences that define the molecular profile.

Dosage and Administration Information

How to Use Plidex: Official Administration Guidelines

Plidex is an oral medication with administration protocols strictly defined to ensure standardized use. These guidelines address the route, dosing, frequency, and specific conditions for intake.


Administration Scope

Instruction Detail
Route of administration Oral administration.
Official dosing rules Starting dose is typically 400 mg, with a maintenance dose of 400 mg per interval, but the maximum total daily intake should not exceed 1200 mg for acute conditions.
Frequency and timing Taken every 6 to 8 hours as needed for symptoms.
Timing in relation to meals Must be taken with food or milk and a full glass of water.
Age-group administration rules For older adults, official guidance mandates initiating treatment at the lowest effective dose for the shortest possible duration.
Special procedural conditions The film-coated tablet must be swallowed whole; it should not be crushed or chewed. Use is limited to short-term symptomatic relief, typically 7 to 10 consecutive days.

Procedural Summary

The official use protocol for Plidex requires taking the designated dose with food and water, swallowing the film-coated tablet intact, and strictly adhering to the maximum 1200 mg daily limit and the short-term duration constraint. This standardized sequence ensures alignment with expectations for intermittent, as-needed use.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Plidex

Evidence for Use in Acute Musculoskeletal Injuries

Short-term Randomized Controlled Trials (RCTs) and systematic reviews have explored the active substance related to conditions like sprains, strains, and tendonitis. Researchers used these studies to explore how symptoms, such as physical discomfort and localized swelling, change over time following an injury. These trials focused on adult populations experiencing acute episodes of injury. The studies reported measurements of symptom change where some groups showed distinct patterns in average pain scores compared to control groups, such as those receiving a placebo.

What remains less clear is the long-term functional data after the initial recovery period. The follow-up durations were limited in these primary studies, meaning there is limited information for long-term outcomes regarding the sustained effects of the substance on the underlying tissue healing process itself. The results apply only to the populations studied, and the evidence quality varies across studies due to differences in injury definition.


Evidence for Managing Acute Flare-ups of Chronic Joint Conditions

Plidex was evaluated in research exploring temporary symptom management during periods of heightened symptom activity associated with chronic joint conditions, such as osteoarthritis (OA) and rheumatoid arthritis (RA). This evidence is derived from both RCTs and Meta-analyses. These studies examined adult populations with specific chronic conditions and often monitored outcomes reflecting daily functioning or activity level, alongside measures of joint pain and tenderness.

What Research Gaps and Uncertainties Remain

A key research limitation is that the primary trials were not designed to study the long-term effects of the substance regarding the overall progression of the chronic disease or structural changes in the joints over many years. Furthermore, comparative evidence is lacking for some of the more minor indications. The research provides context; study results reflect the specific conditions under which they were conducted and describe group patterns, not personal outcomes.

Key Studies & References

  1. NSAIDs: A Review of Analgesic and Anti-Inflammatory Use
  2. NIH MedlinePlus: Pain Relievers (NSAID Overview)

Frequently Asked Questions (FAQ)

Common questions about Plidex (FAQ)


Q: Is Plidex similar to [Name of common competing drug]?

According to official product information, Plidex is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its action is described as the non-selective inhibition of COX-1 and COX-2 enzymes. This mechanism is shared by many other medications in the same pharmacological class.


Q: Are there any foods or drinks I need to avoid while on Plidex?

Official guidance is often recommended to be taken with food or milk and a full glass of water. Additionally, the risk of stomach-related adverse effects is officially increased when this medication is combined with alcohol.


Q: Does Plidex affect sleep?

Reports of adverse reactions documented in official sources include effects on the nervous system, such as dizziness and fatigue. Some NSAIDs are also associated with effects like drowsiness or insomnia.


Q: What if I take Plidex for a condition that is not listed in the main uses?

Plidex has received regulatory approval only for the symptomatic reduction of moderate pain and inflammation related to its specific, officially defined indications. Official documents are silent on the context of use for conditions outside these approved applications.


Q: What are the signs that Plidex might be causing a serious allergic reaction?

Official warnings describe a serious allergic reaction as a possible adverse effect. The label states that signs such as facial swelling or difficulty breathing may occur. Seeking immediate medical attention is necessary if these signs develop.


Q: What are the official warnings about stopping Plidex suddenly?

Official administration guidelines classify Plidex for short-term, as-needed use (typically for short durations like 7 to 10 days). The regulatory documents do not contain explicit warnings related to the process of abrupt discontinuation.


Q: Why does the official document mention a risk for [rare condition]?

Risks for rare conditions are included in official documents based on reported evidence gathered during the clinical development program or from post-market experience that is reviewed by regulatory agencies.


Q: Why does Plidex have a black box warning, what does that mean?

The U.S. FDA requires a Boxed Warning for nearly all NSAIDs. Regulatory documents state that this warning highlights the potential for serious cardiovascular thrombotic events and gastrointestinal bleeding and ulceration, which are significant regulatory concerns.


Q: Does Plidex cause weight gain or weight loss?

Regulatory safety profiles commonly include adverse reactions such as fluid retention or edema. These effects are sometimes associated with the use of NSAIDs and can lead to observable weight changes.


Q: How long does it typically take for Plidex to start working?

Official pharmacokinetic data indicates that the medicine reaches its peak plasma concentration in the bloodstream within approximately one to two hours after oral administration.


Q: What should I do if I forget to take Plidex?

Official patient information advises that since this medicine is taken as needed for symptoms, the recommendation is to take the next dose only when symptoms return. Patient information generally warns against doubling the dose to compensate for a missed one.


Q: Is Plidex a controlled substance?

Official government regulatory classification defines Plidex as a Prescription Only (Rx) medicine. It is not classified as a controlled substance by federal regulatory agencies.


Q: What is the difference between Plidex and a generic version?

Regulatory bodies define a generic version as one that is bioequivalent to the brand-name product and contains the identical active ingredient. The primary differences are typically found in the inactive ingredients and the brand's original patent status.


Q: How long does Plidex stay in your system after you stop taking it?

Pharmacokinetic data shows the medicine has an elimination half-life of approximately two hours. This means it takes about that long for the concentration of the active substance in the body to be reduced by half.


Q: What is the risk of dependence or addiction with Plidex?

Regulatory documents for Plidex do not list dependence or abuse potential as an officially recognized risk. This is consistent with the fact that the medicine is not classified as a controlled substance.


Q: Can Plidex be taken with coffee or caffeine?

Official documents do not include specific warnings regarding the consumption of caffeine or coffee. However, regulatory guidelines generally recommend that Plidex be taken with food or milk and a full glass of water.


Q: Does Plidex affect my ability to drive?

The official label advises that this medication may cause side effects such as dizziness or fatigue. The label further cautions against operating machinery or driving until an individual knows how they respond to the medicine.


Q: What is the expiration date on Plidex packaging?

The official expiration date is determined during the manufacturing process based on stability testing required by regulatory bodies. The date is required to be printed directly on the packaging and bottle label.


Q: What happens if I miss several doses of Plidex?

Official patient guidelines for this as-needed medicine emphasize that the general recommendation is not to exceed the maximum daily limit to try to catch up on missed doses. The regular dosing schedule should be resumed when the next dose is needed for symptoms.


Q: Can I take vitamins or supplements while using Plidex?

Official documentation on drug interactions does not specifically list most common vitamins or supplements. However, the regulatory label recommends that individuals discuss all concurrent products taken, including over-the-counter supplements, with a healthcare professional.


Q: Is Plidex known to interact with grapefruit?

Official regulatory interaction warnings do not mention a specific interaction between Plidex and grapefruit or grapefruit juice.


Q: What is the risk of overdose with Plidex?

The official regulatory document includes a specific section on overdose scenarios. This section describes the symptoms of toxicity that may occur if the maximum recommended dose is significantly exceeded.


Q: Does Plidex affect blood sugar levels?

The official adverse reaction list for Plidex does not commonly report effects on blood sugar levels or glucose metabolism. Users with pre-existing conditions are typically subject to specific monitoring cautions as a regulatory precaution.


Q: Are there any required lab tests before starting Plidex?

Regulatory precautions, particularly for individuals with existing organ impairment or those taking the medicine for longer periods, often suggest the monitoring of renal (kidney) and hepatic (liver) function tests.


Q: Can Plidex interact with herbal remedies?

Official documentation warns that interaction studies may not include data for all herbal products. The label states that some herbal supplements may increase the risk of bleeding when combined with an NSAID.

How should Plidex be stored and disposed of?

How to Store and Dispose of Plidex?

The official regulatory profile for Plidex (Active Substance X film-coated tablet) defines specific conditions to maintain product stability and safety.

Storage Conditions

Plidex must be stored at Controlled Room Temperature, typically below 25 C or 30 C, as specified on the label. The tablets must be kept in their original packaging and protected from light and moisture. Avoid storing the medication in areas prone to excessive heat or humidity, and do not refrigerate or freeze.

Handling and Disposal

It is mandatory to keep Plidex out of the sight and reach of children.

Dispose of any unused or expired tablets via an official medicine take-back program or by mixing the medicine with an unappealing substance, sealing it, and discarding it in the household trash. Do not dispose of the medication via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Plidex found in:

A-Z Index: